Skip to main content
. 2020 Dec 5;12(12):3746. doi: 10.3390/nu12123746

Table 6.

Inhibitory concentration inducing 50% ACE activity inhibition (IC50) of the 11 protein samples before (salivary sample), during (gastric digestion), and after SGID (intestinal digestion).

ACE-IC50 (µg mL−1) Salivary Sample Gastric Digestion Intestinal Digestion
PeaP1 ND 90.70 ± 25.80 CD 101.19 ± 23.15 cd
PeaP2 407.78 ± 28.10 37.37 ± 19.83 D 221.79 ± 45.57 ab
PeaP3 ND 47.38 ± 44.33 CD 185.54 ± 9.97 abc
PeaP4 ND 187.97 ± 45.38 AB 29.54 ± 34.98 d
HPeaP 148.97 ± 40.79 93.37 ± 24.74 CD 113.64 ± 50.51 cd
WP1 ND 60.79 ± 12.22 CD 63.82 ± 20.18 d
WP2 ND 186.78 ± 0.91 AB 265.46 ± 22.88 a
PP ND 107.34 ± 40.79 BCD 85.23 ± 19.24 d
FBP ND 133.50 ± 35.09 BC 52.02 ± 43.06 d
OP ND 98.04 ± 32.21 CD 99.46 ± 9.88 cd
WhP ND 126.38 ± 82.34 BCD 127.50 ± 25.61 bcd

Values are reported as the mean from triplicate determinations with SD. “ND” indicates the IC50 value was too high to be evaluated using this test. Values not sharing any common superscript letter are significantly different according to one-way ANOVA procedure followed by Tukey’s test (intestinal digestions were compared together (a–d, small letters) and gastric digestions together (A–D, capital letters)). PeaP1–PeaP4 (4 grades of pea protein), HPeaP (hydrolyzed pea protein), WP1–WP2 (2 grades of wheat protein), PP (potato protein), FBP (fava bean protein), OP (oat protein) and WhP (Whey protein).